Definitive Healthcare | AI Transformation Index
Definitive Healthcare is a healthcare data intelligence platform at a structural crossroads: the demand for trusted, integrated healthcare market data is d...

Overview
Definitive Healthcare aggregates, cleans, and continuously updates comprehensive healthcare market data (providers, clinicians, claims, consumers, KOLs), then sells access to this intelligence via SaaS subscriptions (View Suite) and supplementary consulting/activation services to life sciences, health IT, financial services, and other healthcare-adjacent organizations.
Executive Summary
Definitive Healthcare is a healthcare data intelligence platform at a structural crossroads: the demand for trusted, integrated healthcare market data is durable, but the company's role as the privileged aggregator of that data is under increasing pressure from AI-enabled synthesis and well-resourced incumbents who can build comparable datasets into existing workflow platforms. The AI opportunity is real — particularly the potential to reposition from a static data subscription toward a dynamic AI-native intelligence layer — but Definitive Healthcare has an advanced internal engineering team already working this angle, so the unrealized step-change is incremental rather than transformative. For Advent, the strategic imperative is to accelerate the product's evolution toward an AI-native intelligence platform before IQVIA or Veeva absorbs the use case into their broader suites; the window to defend the standalone data layer is narrowing.
Durability
How resilient is this business against AI disruption?
Market Substitutability
Profit Pool Migration
Barrier to Entry
Disintermediation Exposure
Switching Costs
Opportunity
How big a deal is AI for this business?
AI Applicability
Improvement Magnitude
Transformation Upside
Domain Intelligence Amplification
51.4
Ciridae AI Score
Durability Rationale
Definitive Healthcare occupies a structurally precarious layer in the healthcare intelligence value chain: it is an information intermediary whose moat rests on data aggregation depth and workflow embedding rather than physical assets, regulatory gatekeeping, or irreplaceable expert judgment. The core threat is not that demand for healthcare market intelligence disappears — it won't — but that the barriers to approximating that intelligence are dissolving as AI lowers the cost of data synthesis and as better-capitalized incumbents (IQVIA, Veeva) and AI-native entrants close the quality gap. Moderate switching costs and HIPAA data complexity provide real but not decisive protection, and the ongoing revenue decline is an early signal that the profit pool is already migrating toward platforms with deeper workflow control or richer data supply chains.
Opportunity Rationale
The AI opportunity for Definitive Healthcare is real but already partially in flight: as a tech-native company with an advanced engineering team, the self-sufficiency discount applies — the most obvious AI improvements to data pipelines, enrichment, and analytics are already being pursued internally. The bigger opportunity is architectural: AI could transform the product from a structured data subscription into a dynamic intelligence platform where commercial users ask natural-language questions, receive synthesized market insights, and trigger activation workflows autonomously — expanding into user segments that the current analyst-centric product doesn't serve. The domain intelligence embedded in the provider graph and claims asset is a genuine amplifier, but its mostly systematic rather than deeply judgment-based nature caps the O4 upside relative to businesses with rich experiential knowledge stores.
Key Risks
The durability view could be wrong if Definitive Healthcare's depth of claims integration and validated provider graph turns out to be significantly harder to replicate than anticipated — if the data supply chain moat proves stickier than the revenue trends suggest, the intermediary layer may be more defensible than the current displacement narrative implies.
The opportunity view could be wrong if the self-sufficiency discount is understated — with an advanced engineering team and ongoing AI initiatives already in production, the incremental Opportunity from external AI catalysis may be smaller than it appears, particularly if the company is further along the AI transformation curve than publicly visible.
Company Overview
| Headquarters | Framingham, Massachusetts, United States |
| Products / Services | Comprehensive healthcare market data covering health systems, hospitals, physicians, physician groups, surgery centers, imaging centers, long-term care facilities, and clinicsConsolidated affiliations, referrals, quality metrics, financials, and clinical metricsConsumer data including HIPAA-compliant healthcare consumer behavior insightsAll-payor medical and prescription claims dataInsights into medical and scientific experts, including key opinion leadersStrategic services including data science, advanced analytics, consulting, and integration of insights into workflowsActivation services for digital advertising campaigns targeting the healthcare market |
| Deal Partners |
AI & Tech Initiatives
| Name | Description |
|---|---|
| Agentic AI in Healthcare Operations | In 2025, Definitive Healthcare highlighted the shift from assistive generative AI tools (which support human workflows) to agentic AI systems capable of autonomous task completion with minimal human input. Agentic AI acts independently to complete end-to-end tasks across healthcare workflows, representing a paradigm shift toward autonomous systems in healthcare operations. |
| Generative AI and LLMs in Healthcare | Generative AI and LLMs have been used primarily for content generation tasks such as clinical documentation, summarizing patient histories, and automating prior authorization requests. These tools reduce administrative burden but are task-specific and do not orchestrate complex workflows. |
PE / Ownership History
| Event | Details |
|---|---|
Definitive Healthcare Voting Agreement with Advent International November 7, 2024 | Definitive Healthcare and Advent International entered into a voting agreement related to stock repurchase programs and voting securities. |
Advent International Investment in Definitive Healthcare June 7, 2019 | Advent International joined as an investor in Definitive Healthcare alongside Founder and CEO Jason Krantz and Spectrum Equity. This was a significant private equity investment to accelerate product expansion and growth. |
Executives
| Name | Background |
|---|---|
Kevin Coop Chief Executive Officer (CEO) | CEO since June 2024, also a member of the Board of Directors. CEO and board member at DailyPay, Inc. (financial services work technology company) from June 2022 to June 2024. Various leadership roles at Dun & Bradstreet Holdings, Inc. (commercial data, analytics, and insights company) from January 2019 to June 2022, including President of North America, Chief Commercial Officer, and Chief Revenue Officer. President of Data Analytics division at Black Knight, Inc. (software, data, and analytics for mortgage and real estate) from January 2014 to February 2019. Executive Vice President of ServiceLink, a Fidelity National Financial subsidiary, from December 2012 to January 2014. President of Financial Services business lines at Verisk Analytics, Inc. (data analytics company) from May 2005 to December 2012. Bachelor of Arts in History and Political Science from UCLA. |
Casey Heller Chief Financial Officer (CFO) | CFO since January 2024 (previously Senior Vice President of Finance). Nearly 15 years at IBM in leadership roles including Vice President of Investor Relations, Director of Investor Relations, Director of Treasury Strategy, Chief of Staff to the CFO, and FP&A lead for the software business. Completed CFO Program at Columbia Business School Executive Education. |
Ben Graboske Executive Vice President Technology & Engineering, Chief Data Officer | Leads data strategy, product innovation, and engineering globally. President of Mortgage Data & Analytics at ICE (financial services company). President of Data & Analytics at Black Knight, Inc. Senior Vice President of Real Estate & Financial Services at CoreLogic. Vice President of Mortgage and Analytics Technology at Interthinx. Chief Information Officer at Move, Inc. & Realtor.com. Bachelor of Arts in Physics and French from University of California, Berkeley. |
Jeannine Lombardi Chief Human Resources Officer (CHRO) | Joined June 2025, leads HR strategy and talent development. Chief People Officer at Ginkgo Bioworks. Over 20 years in HR leadership across life sciences, data, and technology sectors. Bachelor of Science from Emmanuel College; Master’s in Human Resource Management from Cornell University. |
Jonathan Paris Chief Legal Officer and Secretary | Leads legal department, corporate governance, and compliance. General Counsel & Head of Corporate Strategy at FluidForm Bio. Senior Vice President, Secretary, and General Counsel at Rapid Micro Biosystems. Leadership roles at Insulet Corporation, Medtronic, and Covidien. Bachelor of Arts in Economics & Government from Colby College; Master of Science in Finance and Juris Doctor from Suffolk University. |
Tina Hannagan Chief Commercial Officer (CCO) | Leads go-to-market strategy, sales, marketing, and customer success. Executive Vice President and General Manager at Fusable. Senior Vice President of Shared Services at Dun & Bradstreet. MBA and Bachelor of Science in Economics from University of Delaware. |
Kate Hastings Chief Customer Officer | Leads Customer Experience team including Customer Success and Support. Operational partner at WCAS. Led Customer Experience and Insights at LinkedIn. Experience with Gartner and McKinsey. |
Advent International